Aetna and Humana shareholders on Monday voted to approve a merger between the two companies, Modern Healthcare reports.
Aetna in a in a statement said 99% of its voting shares approved the merger, while in a separate statement said 99% its voting shares also approved the deal.
In July, Aetna announced it reached a $37 billion deal to purchase Humana, which could make Aetna the nation’s second-largest insurer. A Kaiser Family Foundation report determined, “If the deal between Aetna and Humana proceeds, the consolidated firm would provide coverage to more than one-quarter — 26% — of all Medicare Advantage enrollees nationwide, making it the leading Medicare Advantage insurer.”
Federal regulators must approve the proposal, and antitrust experts say the Department of Justice and state attorneys general are likely to scrutinize it closely. DOJ is reviewing the deal to determine whether it would “substantially … lessen competition” and thus violate the Clayton Antitrust Act of 1914.
In addition, the deal must meet certain closing conditions. The two insurers expect the deal to be completed by the second half of 2016.
Full content: Modern Healthcare
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas